MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202631093765 A) filed by Ipfc-Giet University Cell on August 03, 2026, for A Smart Closed-Loop Bi-Hormonal Transdermal Patch Device For Continuous Glucose Monitoring And Dual Hormone Delivery.
Inventors include Kolla Venkata Atchuta Rao; Pushpavalli Rokkala; Nitesh Kumar Khatarkar; and Dr. Avnl Sharma.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: ABSTRACT A SMART CLOSED-LOOP BI-HORMONAL TRANSDERMAL PATCH DEVICE FOR CONTINUOUS GLUCOSE MONITORING AND DUAL HORMONE DELIVERY 5 10 15 The present invention relates to a smart, closed-loop bi-hormonal transdermal patch device (100) for continuous glucose monitoring and dual-hormone delivery. The device (100) comprises a housing including an upper housing shell (102) and a lower housing section (107) enclosing a reusable PCB controller (203), segregated insulin and glucagon reservoir and pump assemblies (204), a thermo-pneumatic actuation element (300), biodegradable insulin and glucagon microneedle patches (206), and a continuous glucose monitoring sensor patch (208) configured for active interstitial fluid sampling and dual-channel electrochemical detection to enable automated closed-loop glycemic management.
Disclaimer: Curated by HT Syndication.
